Seeking Alpha

ONTY
  Oncothyreon Inc . - NASDAQ

10/22/2014, 10:05 PM ET
  • Joseph P. Porter | Send Message 19 Dec 2012

    $ONTY takes it on the chin after the failure of a lung-cancer treatment. The risk in small bio-pharms: bad-news drops are a way of life.
    Reply
      ONTY vs. ETF Alternatives
      Company Description
      Oncothyreon Inc is a clinical-stage biopharmaceutical company. It develops and commercialize synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States